Naltrexone treatment produces dose-related effects on food and water intake but daily alcohol consumption is not affected

Nutritional Neuroscience

Volumn 11, Issue 4, 2008, Pages 183-192

  Juárez, Jorge ^a   De Tomasi, Eliana Barrios ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Alcohol; Ethanol; Food intake; Naltrexone; Opioid antagonists; Water intake

Indexed keywords

ALCOHOL; NALTREXONE; SODIUM CHLORIDE; WATER;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; FLUID INTAKE; FOOD INTAKE; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE;

ALCOHOL DRINKING; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; EATING; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; RATS; RATS, WISTAR;

RATTUS;

EID: 50449109610     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/147683008X301577     Document Type: Article

References (57)

1. Gianoulakis C. Characterization of the effects of acute ethanol administration on the release of beta-endorphin peptides by the rat hypothalamus. Eur J Pharmacol 1990; 180 21-29.
2. Gianoulakis C, Krishnan B, Thavundayil J. Enhanced sensitivity of pituitary β-endorphine to ethanol in subjects at high risk of alcoholism. Arch Gen Psychiatry 1996; 53: 250-257.
3. O'Malley SS. Opioid antagonist in the treatment of alcohol dependence: clinical efficacy and prevention of relapse. Alcohol Alcohol 1996; 1: 77-81.
4. Volpicelli JR, Clay KL, Watson NT, O'Brien CP. Naltrexone in the treatment of alcoholism: predicting response to naltrexone. J Clin Psychiatry 1995; 56: 39-44.
5. Guardia J, Caso C, Arias F et al. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial. Alcohol Clin Exp Res 2002; 26: 1381-1387.
6. McCaul ME, Wand GS, Stauffer R, Lee SM, Rohde CA. Naltrexone dampens ethanol-induced cardiovascular and hypothalamic-pituitary-adrenal axis activation. Neuropsychopharmacology 2001; 25: 537-547.
7. Heinälä P, Alho H, Kiianmaa K, Lonnqvist J, Kuoppasalmi K, Sinclair JD. Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial. J Clin Psychopharmacol 2001; 21: 287-292.
8. Sinclair JD. Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol Alcohol 2001; 36: 2-10.
9. Hyytia P, Ingman K, Soini SL, Laitinen JT, Korpi ER. Effects of continuous opioid receptor blockade on alcohol intake and upregulation of opioid receptor subtype signaling in a genetic model of high alcohol drinking. Naunyn-Schmiedeberg's Arch Pharmacol 1999; 360: 391-401.
10. Gardell LR, Hubbell CHL, Reid LD. Naltrexone persistently reduces rats' intake of a palatable alcoholic beverage. Alcohol Clin Exp Res 1996; 20: 584-588.
11. Gardell LR, Reid LD, Boedeker KL, Liakos TM, Hubell CL. Isradipine and naltrexone in combination with isradipine interact with a period of abstinence to reduce rats' intakes of an alcoholic beverage. Alcohol Clin Exp Res 1997; 21: 1592-1598.
12. Gardell LR, Whalen CA, Chattophadyay S, Cavallaro CA, Hubbell CL, Reid LC. Combination of naltrexone and fluoxetine on rats propensity to take alcoholic beverage. Alcohol Clin Exp Res 1997; 21: 1435-1439.
13. Williams KL, Woods JH. Naltrexone reduces ethanol and/or water-reinforced responding in rhesus monkeys: effect depends upon ethanol concentration. Alcohol Clin Exp Res 1999; 23: 1462-1467.
14. Hill KG, Kiefer W. Naltrexone treatment increases the aversiveness of alcohol for outbred rats. Alcohol Clin Exp Res 1997; 21: 637-642.
15. Stromberg MF, Volpicelli JR, O'Brien CP. Effects of naltrexone administered repeatedly across 30 and 60 days on ethanol consumption using a limited access procedure in the rat. Alcohol Clin Exp Res 1998; 22: 2186-2191.
16. Stromberg MF, Sengpiel T, Mackler SA, Volpicelli JR, O'Brien CP, Vogel WH. Effect of naltrexone on oral consumption of concurrently available ethanol and cocaine in the rat. Alcohol 2002; 28: 169-179.
17. Parkes H, Sinclair JD. Reduction of alcohol drinking and upregulation of opioid receptors by oral naltrexone in AA rats. Alcohol 2000; 21: 215-221.
18. Reid LD, Gardell LR, Chattopadhyay S, Hubbell ChL. Periodic naltrexone and propensity to take alcoholic beverage. Alcohol Clin Exp Res 1996; 20: 1329-1334.
19. Goodwin FL, Campisi M, Babinska I, Amit Z. Effects of naltrexone on the intake of ethanol and flavored solutions in rats. Alcohol 2001; 25: 9-19.
20. Coonfield DL, Kiefer SW, Ferraro 3rd FM, Sinclair JD. Ethanol palatability and consumption by high ethanol-drinking rats: manipulation of the opioid system with naltrexone. Behav Neurosci 2004; 118: 1089-1096.
21. Phillips TJ, Wenger ChD, Dorow JD. Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6J mice. Alcohol Clin Exp Res 1997; 21: 691-702.
22. Lang IM, Strahlendorf JC, Strahlendorf HK, Barnes CD. Effects of chronic administration of naltrexone on appetitive behaviors of rats. Prog Clin Biol Res 1981; 68: 197-207.
23. Marks-Kaufman R, Balmagiya T, Gross E. Modification in food intake and energy metabolism in rats as a function of chronic naltrexone infusions. Pharmacol Biochem Behav 1984; 20, 911-916.
24. Jones JE, Corp ES. Effect of naltrexone on food intake and body weight in Syrian hamsters depends on metabolic status. Physiol Behav 2003; 78: 67-72.
25. Kotz CM, Glass MJ, Levine AS, Billington CJ. Regional effect of naltrexone in the nucleus of the solitary tract in blockade of NPY-induced feeding. Am J Physiol 2000; 278: R499-R503.
26. Davidson D, Amit Z. Effect of ethanol drinking and naltrexone on subsequent drinking in rats. Alcohol 1997; 14: 581-584.
27. Bertino M, Beauchamp GK, Engelman K. Naltrexone, an opioid blocker, alters taste perception and nutrient intake in humans. Am J Physiol 1991; 261: R59-R63.
28. Spiegel TA, Stunkard AJ, Shrager EE, O'Brien CP, Morrison MF, Stellar E. Effect of naltrexone on food intake, hunger and satiety in obese men. Physiol Behav 1987; 40: 135-141.
29. Yeomans MR, Gray RW. Opioid peptides and the control of human ingestive behaviour. Neurosci Biobehav Rev 2002; 26: 713-728.
30. Yeomans, MR, Gray, RW. Effects of naltrexone on food intake and changes in subjective appetite during eating: evidence for opioid involvement in the appetizer effect. Physiol Behav 1997; 62: 15-21.
31. Lang IM, Strahlendorf JC, Strahlendorf HK, Lutherer LO, Barnes CD. The effects of chronic administration of naltrexone on appetitive and water exchange in rats. Pharmacol Biochem Behav 1982; 16: 909-913.
32. Tannenbaum MG, Pivorun EB. Effect of naltrexone on food intake and hoarding in white-footed mice (Peromyscus). Pharmacol Biochem Behav 1984; 20: 35-37.
33. Kirkham TC, Blundell JE. Effects of naloxone and naltrexone on meal patterns of freely-feeding rats. Pharmacol Biochem Behav 1987; 26: 515-520.
34. Hobbs DJ, Koch JE, Bodnar RJ. Naltrexone, dopamine receptor agonists and antagonists and food intake in rats: 1. Food deprivation. Pharmacol Biochem Behav 1994; 49: 197-204.
35. MacDonald AF, Billington CJ, Levine AS. Effects of the opioid antagonist naltrexone on feeding induced DAMGO in the ventral tegmental area and in the nucleus accumbens shell region in the rat. Am J Physiol 2003; 285: R999-R1004.
36. Littleton J, Zieglgänsberger W. Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence. Am J Addict 2003; 12 (Suppl 1): S3-S11.
37. Kornet M, Goosen C, Van Ree JM. Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacology 1991; 104: 367-376.
38. González JP, Brogden RN. Naltrexone: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs 1988; 35: 192-213.
39. Sinclair JD. Drugs to decrease alcohol drinking. Ann Med 1990; 22: 357-362.
40. Juárez J, Barrios De Tomasi E. Alcohol consumption is enhanced alter naltrexone treatment. Alcohol Clin Exp Res 2007; 31: 260-264.
41. Biggs TA, Myers RD. Naltrexone and amperozide modify chocolate and saccharin drinking in high alcohol-preferring P rats. Pharmacol Biochem Behav 1998; 60: 407-413.
42. Hölter SM, Spanagel R. Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats. Psychopharmacology 1999; 145: 360-369.
43. Hollister LE, Johnson K, Boukhabza D, Gillespie HK. Aversive effects of naltrexone in subjects not dependent on opiates. Drug Alcohol Depend 1981; 8: 37-41.
44. Kanarek RB, Mathes WF, Heisler LK, Lima RP, Monfared LS. Prior exposure to palatable solutions enhances the effects of naltrexone on food intake in rats. Pharmacol Biochem Behav 1997; 57: 377-381.
45. Apfelbaum M, Mandenoff A. Naltrexone suppresses hyperphagia induced in the rat by a highly palatable diet. Pharmacol Biochem Behav 1981; 15: 89-91.
46. Cooper SJ, Turkish S. Effects of naltrexone on food preference and concurrent behavioral responses in food-deprived rats. Pharmacol Biochem Behav 1989; 33: 17-20.
47. Chen RZ, Huang RR, Shen CP, MacNeil DJ, Fong TM. Chronic administration of nalmefene leads to increased food intake and body weight gain in mice. Eur J Pharmacol 2004; 495: 63-66.
48. Rukstalis MR, Stromberg MF, O'Brien CP, Volpicelli JR. 6-beta-naltrexole reduces alcohol consumption in rats. Alcohol Clin Exp Res 2000; 24: 1593-1596.
49. Stomberg MF, Rukstalis MR, Mackler SA, Volpicelli JR, O'Brien CP. A comparison of the effects of 6-beta naltrexole and naltrexone on the consumption of ethanol or sucrose using a limited-access procedure in rats. Pharmacol Biochem Behav 2002; 72: 483-490.
50. Gosnell BA, Levine AS, Morley JE. The stimulation of food intake by selective agonists of mu, kappa and delta opioid receptors. Life Sci 1986; 38: 1081-1088.
51. Morley JE, Levine AS, Kneip J, Grace M, Zeugner H, Shearman GT. The kappa opioid receptor and food intake. Eur J Pharmacol 1985; 112: 17-25.
52. Jackson A, Cooper SJ. Effects of kappa opiate agonists on palatable food consumption in non-deprived rats, with and without food preloads. Brain Res Bull 1985; 15: 391-396.
53. Nencini P, Graziani M. Opiatergic modulation of preparatory and consummatory components of feeding and drinking. Pharmacol Biochem Behav 1990; 37: 531-537.
54. Jarosz PA, Metzger BL. The effect of opioid antagonism on food intake behavior and body weight in a biobehavioral model of obese binge eating. Biol Res Nurs 2002; 3: 198-209.
55. de Zwaan M, Mitchell JE. Opiate antagonists and eating behavior in humans: a review. J Clin Pharmacol 1992; 32: 1060-1072.
56. Barg J, Belcheva M, McHale R, Levy R, Vogel Z, Coscia CJ. Beta-endorphin is a potent inhibitor of thymidine incorporation into DNA via mu- and kappa-opioid receptor in fetal rat brain cell aggregates in culture. J Neurochem 1993; 60: 765-767.
57. Tseng LF, Henneberry B, Collins KA. The antinociception induced by beta-endorphin administered intrathecally is mediated by the activation of mu- and kappa-opioid receptors in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 1995; 351: 464-468.